A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes
- 96 Downloads
Contrast-induced nephropathy (CIN) is a common complication in patients undergoing coronary angiography (CAG) or percutaneous coronary intervention (PCI) and associated with poor outcome. Some previous studies have already set up models to predict CIN, but there is no model for patients with diabetes mellitus (DM) especially. Therefore, we aim to develop and validate a simple risk score for predicting the risk of CIN in patients with DM undergoing CAG/PCI.
A total of 1157 consecutive patients with DM undergoing CAG/PCI were randomly assigned to a development cohort (n = 771) and a validation cohort (n = 386). The primary endpoint was CIN, which was defined as an absolute increase in serum creatinine (SCr) by 0.5 mg/dL from the baseline within 48–72 h after contrast exposure. The independent predictors for CIN were identified by multivariate logistic regression, and the discrimination and calibration of the risk score were assessed by ROC curve and Hosmer–Lemeshow test, respectively.
The overall incidence of CIN was 45 (3.9%). The new simple risk score (Chen score), which included four independent variables (age > 75 years, acute myocardial infarction, SCr > 1.5 mg/dL, the use of intra-aortic balloon pump), exhibited a similar discrimination and predictive ability on CIN (AUC 0.813, 0.843, 0.796, P > 0.05, respectively), mortality (AUC 0.735, 0.771, 0.826, respectively) and MACEs when being compared with the classical Mehran or ACEF risk score.
Our data suggest that the new simple risk score might be a good tool for predicting CIN in patients with DM undergoing CAG/PCI.
KeywordsContrast-induced nephropathy Diabetes mellitus Risk score model Coronary angiography Percutaneous coronary intervention
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
The study was approved by the Ethics Research Committee of Guangdong General Hospital.
We provided all individual patients with the option to opt out of participation.
- 1.McCullough PA. Contrast-induced nephropathy: definitions, epidemiology, and implications. Interv Cardiol Clin. 2014;3(3):357–62.Google Scholar
- 3.Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv. 2014;7(1):1–9.CrossRefGoogle Scholar
- 6.Ohno I, Hayashi H, Aonuma K, Horio M, Kashihara N, Okada H et al.; Japanese Society of Nephrology, Japan Radiological Society, and Japanese Circulation Society Science Advisory and Coordinating Committee. Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version: JSN, JRS, and JCS Joint Working Group. Clin Exp Nephrol. 2013;17(4):441–79.CrossRefGoogle Scholar
- 7.Sun G, Chen P, Wang K, Li H, Chen S, Liu J, He Y, Song F, Liu Y, Chen JY. Contrast-induced nephropathy and long-term mortality after percutaneous coronary intervention in patients with acute myocardial infarction. Angiology. 2018;15:3319718803677. https://doi.org/10.1177/0003319718803677.Google Scholar
- 10.Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol. 2004;44(7):1393–9.Google Scholar
- 13.Liu Y, Chen JY, Tan N, Zhou YL, Yu DQ, Chen ZJ, et al. Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathy. Circ Cardiovasc Interv. 2015;8(6):e1859.CrossRefGoogle Scholar
- 15.Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:155A (abstract).Google Scholar
- 22.Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, et al. Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry. J Am Heart Assoc. 2014;3(6):71–9.CrossRefGoogle Scholar
- 26.Bouzasmosquera A, Vázquezrodríguez JM, Calviñosantos R, Peteirovázquez J, Floresríos X, Marzoarivas R, et al. Contrast-induced nephropathy and acute renal failure following emergent cardiac catheterization: incidence, risk factors and prognosis. Rev Esp Cardiol. 2007;60(10):1026–34.CrossRefGoogle Scholar
- 29.Tziakas D, Chalikias G, Stakos D, Apostolakis S, Adina T, Kikas P, et al. Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice. Int J Cardiol. 2013;163(1):46–55.CrossRefGoogle Scholar